An interventional study of Immediate standing dual task training and progressive standing dual task training in Cognitive Impairment, Cognitive Impairment, Mild and Moderate Cognitive Impairment, sponsored by Shifa Tameer-e-Millat University. Recruiting at 1 site in Pakistan. Open to participants aged 55 Years and older. Per ClinicalTrials.gov, last updated 2026-09-01.
Sponsored by Shifa Tameer-e-Millat University · Not applicable, Interventional, and Treatment
older adults with mild and moderate cognitive impairment. compare immediate vs progressive standing dual-task training. assess balance, cognition, executive function, mobility, and quality of life.
3,872 studies on the registry are indexed under Cognitive Dysfunction; 1,119 are open to participants now.
This study's planned enrollment of 96 is above the median of 64 across 2,794 interventional studies indexed under Cognitive Dysfunction.
Browse Cognitive Dysfunction studies →Shifa Tameer-e-Millat University is the lead sponsor of 27 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: Immediate standing dual task training
Other: progressive standing dual task training
Other: Immediate standing dual task training
Other: progressive standing dual task training
Motor-cognitive dual-task training is a rehabilitation intervention delivered by a physiotherapist over 8 weeks, with three sessions per week, each lasting 45 minutes. Every session consists of a 5-minute warm-up, 30-35 minutes of dual-task training, and a 5-minute cool-down. It simultaneously combines motor and cognitive tasks. Motor components include marching in place, finger tapping, hand transfer activities, side stepping, weight shifting, heel raises, heel-toe stepping, and balance challenges. Cognitive components include naming animals or fruits, counting forward, and months, serial subtraction by threes, backward digit span, alternate naming, and word recall. Participants allocated to the Immediate Standing intervention perform all dual-task activities in standing from the first treatment session.
Motor-cognitive dual-task training is a rehabilitation intervention delivered by a physiotherapist over 8 weeks, with three sessions per week, each lasting 45 minutes. Every session consists of a 5-minute warm-up, 30-35 minutes of dual-task training, and a 5-minute cool-down. It simultaneously combines motor and cognitive tasks. Motor components include marching in place, finger tapping, hand transfer activities, side stepping, weight shifting, heel raises, heel-toe stepping, and balance challenges. Cognitive components include naming animals or fruits, counting forward, and months, serial subtraction by threes, backward digit span, alternate naming, and word recall. Participants allocated to the Progressive Standing intervention initially perform dual-task activities sitting and progressively transition to standing during the intervention period.
Mini-Mental State Examination
The Mini-Mental State Examination (MMSE) is a 30-point measure of global cognitive function. Scores range from 0 to 30, with higher scores indicating better cognitive function
Time frame: Baseline and Week 8
Berg Balance Scale
The Berg Balance Scale (BBS) is a 14-item clinical measure of static and dynamic balance. Total scores range from 0 to 56, with higher scores indicating better balance performance.
Time frame: Baseline and Week 8
Timed Up and Go
The Timed Up and Go Test measures functional mobility. The outcome is the time (seconds) required to stand from a chair, walk 3 meters, turn, return, and sit. Lower completion times indicate better mobility.
Time frame: Baseline and Week 8
Trail Making Test
The Trail Making Test Part assesses executive function and cognitive flexibility. The outcome is the time (seconds) required to complete the test. Lower completion times indicate better executive function.
Time frame: Baseline and Week 8
Quality of Life in Alzhiemer's Disease Scale
The Quality of Life in Alzheimer's Disease (QoL-AD) questionnaire consists of 13 items, with total scores ranging from 13 to 52. Higher scores indicate better quality of life.
Time frame: Baseline and Week 8
Plan to share: No
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shifa Tameer-e-Millat University